Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer

Condition:   Non Small Cell Lung Cancer Intervention:   Drug: Individualized neoantigen peptides vaccine Sponsors:   Sun Yat-sen University;   Tianjin Hengjia Biotechnology Development co., LTD Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials